Trade Summary

7 months ago, Pamir Ozan, serving as CFO at Niagen Bioscience, Inc. (NAGE), purchased 6,685 shares at $6.82 per share, for a total transaction value of $45,616.00. Following this transaction, Pamir Ozan now holds 9,593 shares of NAGE.

This purchase represents a 230.00% increase in Pamir Ozan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, November 14, 2025 and publicly disclosed via SEC Form 4 filing on Monday, November 17, 2025 at 3:23 AM ET, 3 days after the trade was made.

Niagen Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.